CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele
- PMID: 16636685
- DOI: 10.1038/sj.tpj.6500390
CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele
Abstract
Human cytochrome P450 (CYP) 2A6 metabolizes nicotine to cotinine. Genetic polymorphisms of CYP2A6 contribute to the interindividual variability of nicotine metabolism. We encountered some subjects possessing two copies of the CYP2A6 gene, although they were genotyped as heterozygotes of the CYP2A6*4A allele (entire CYP2A6 gene deleted allele). From the subjects, we found CYP2A7 polymorphic alleles (CYP2A7*1B, CYP2A7*1C, and CYP2A7*1D) in which the sequences in the 3'-flanking region were converted to the corresponding CYP2A6 sequences, being confused with the CYP2A6*4A. These allele frequencies in European-Americans (n=187) were 1.3, 2.1, 0.3%, respectively, but these were very rare in African-Americans (n=176), Japanese (n=184), and Koreans (n=209). By an improved genotyping method, the allele frequency of CYP2A6*4A of 3.7% in European-Americans was corrected to 0%. The comprehensible and reliable genotyping method developed in this study would be useful to evaluate associations between the genotype and phenotype.
Similar articles
-
Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.Clin Pharmacol Ther. 2006 Sep;80(3):282-97. doi: 10.1016/j.clpt.2006.05.012. Clin Pharmacol Ther. 2006. PMID: 16952495 Clinical Trial.
-
Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.Drug Metab Dispos. 2005 Aug;33(8):1202-10. doi: 10.1124/dmd.105.004994. Epub 2005 May 17. Drug Metab Dispos. 2005. PMID: 15900015 Clinical Trial.
-
A novel duplication type of CYP2A6 gene in African-American population.Drug Metab Dispos. 2007 Apr;35(4):515-20. doi: 10.1124/dmd.106.013557. Epub 2007 Jan 31. Drug Metab Dispos. 2007. PMID: 17267622
-
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.Drug Metab Pharmacokinet. 2005 Aug;20(4):227-35. doi: 10.2133/dmpk.20.227. Drug Metab Pharmacokinet. 2005. PMID: 16141602 Review.
-
Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.Drug Metab Dispos. 2001 Feb;29(2):91-5. Drug Metab Dispos. 2001. PMID: 11159795 Review.
Cited by
-
Relationship between amounts of daily cigarette consumption and abdominal obesity moderated by CYP2A6 genotypes in Chinese male current smokers.Ann Behav Med. 2012 Apr;43(2):253-61. doi: 10.1007/s12160-011-9318-5. Ann Behav Med. 2012. PMID: 22160797 Free PMC article.
-
Associations of CYP2A6 genotype with smoking behaviors in southern China.Addiction. 2011 May;106(5):985-94. doi: 10.1111/j.1360-0443.2010.03353.x. Addiction. 2011. PMID: 21205058 Free PMC article.
-
Human Orphan Cytochromes P450: An Update.Curr Drug Metab. 2022;23(12):942-963. doi: 10.2174/1389200224666221209153032. Curr Drug Metab. 2022. PMID: 36503398
-
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.Clin Pharmacol Ther. 2008 Jan;83(1):115-21. doi: 10.1038/sj.clpt.6100246. Epub 2007 May 23. Clin Pharmacol Ther. 2008. PMID: 17522595 Free PMC article. Clinical Trial.
-
Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction.EXCLI J. 2017 Mar 6;16:174-196. doi: 10.17179/excli2016-847. eCollection 2017. EXCLI J. 2017. PMID: 28507465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases